Free
Corrections  |   September 2010
Corrections
Article Information
Corrections   |   September 2010
Corrections
The Journal of the American Osteopathic Association, September 2010, Vol. 110, 508. doi:10.7556/jaoa.2010.110.9.508
The Journal of the American Osteopathic Association, September 2010, Vol. 110, 508. doi:10.7556/jaoa.2010.110.9.508
The JAOA regrets errors that appeared in the following contribution: 

MacDonald GP. Cost-effectiveness of rosuvastatin for primary prevention of cardiovascular events according to Framingham Risk Score for patients with elevated C-reactive protein. J Am Osteopath Assoc. 2010;110(8):427-436.

 
In Table 3 under “FRS >10%” for “Cost of statin per tablet,” the corresponding amount in the column “Biased Toward Statin” was incorrectly printed as $1000. This amount should have been -$1000. 
In addition, the blue graph line in Figure 4 was incorrectly labeled “Framingham Risk Score <10%.” The label should have appeared as “Framingham Risk Score >10%.” 
These changes will be made to the full text (http://www.jaoa.org/cgi/content/full/110/8/427) and PDF (http://www.jaoa.org/cgi/reprint/110/8/427) versions online.